Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

CUSIP: 34962G109

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
20,563,488
Total 13F shares
18,862,822
Share change
+128,516
Total reported value
$15,499,549
Put/Call ratio
1.7%
Price per share
$0.82
Number of holders
34
Value change
+$107,364
Number of buys
8
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13F
Company
18%
3,624,548
$2,399,451 30 Sep 2023
13F
PERCEPTIVE ADVISORS LLC
13F
Company
16%
3,265,359
$2,161,667 30 Sep 2023
13F
BVF INC/IL
13F
Company
15%
2,982,105
$1,974,154 30 Sep 2023
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
8.9%
1,838,965
$1,217,395 30 Sep 2023
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
8.8%
1,810,455
$1,198,521 30 Sep 2023
13F
BML Capital Management, LLC
13F
Company
8.6%
1,761,702
$1,166,247 30 Sep 2023
13F
VANGUARD GROUP INC
13F
Company
3.2%
664,830
$440,117 30 Sep 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1%
208,383
$138,009 30 Sep 2023
13F
BlackRock Finance, Inc.
13F
Company
0.89%
182,164
$120,592 30 Sep 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.62%
126,900
$84,000 30 Sep 2023
13F
STATE STREET CORP
13F
Company
0.2%
41,664
$27,582 30 Sep 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.2%
41,364
$27,383 30 Sep 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.16%
33,756
$22,346 30 Sep 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.13%
26,991
$17,868 30 Sep 2023
13F
NORTHERN TRUST CORP
13F
Company
0.13%
26,911
$17,815 30 Sep 2023
13F
GROUP ONE TRADING LLC
13F
Company
0.08%
15,827
$10,477 30 Sep 2023
13F
Aries Wealth Management
13F
Company
0.06%
13,000
$7,540 30 Sep 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
10,763
$7,125 30 Sep 2023
13F
HSBC HOLDINGS PLC
13F
Company
0.05%
10,745
$6,970 30 Sep 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
3,181
$2,106 30 Sep 2023
13F
Cutler Group LLC / CA
13F
Company
0.02%
3,987
$2,000 30 Sep 2023
13F
UBS Group AG
13F
Company
0.01%
2,471
$1,636 30 Sep 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
1,080
$714 30 Sep 2023
13F
MORGAN STANLEY
13F
Company
0%
994
$658 30 Sep 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
647
$428 30 Sep 2023
13F
Russell Investments Group, Ltd.
13F
Company
0%
453
$299 30 Sep 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
235
$156 30 Sep 2023
13F
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
13F
Company
0%
193
$92 30 Sep 2023
13F
JPMORGAN CHASE & CO
13F
Company
0%
17
$11 30 Sep 2023
13F
Qube Research & Technologies Ltd
13F
Company
0%
3
$2 30 Sep 2023
13F
Patricia S. Walker
3/4/5
Director
class O/S missing
25,000
01 Jun 2022

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q4 2023

As of 31 Dec 2023, Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,862,822 shares. The largest 10 holders included TYBOURNE CAPITAL MANAGEMENT (HK) LTD, PERCEPTIVE ADVISORS LLC, BVF INC/IL, Cable Car Capital LLC, FRED ALGER MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc.. This page lists 34 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
30
Q4 2023 holders
34
Holder diff
4
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .